Skip to main content
SpringerLink
Log in

Pathogenesis of atherosclerosis: State of the art

  • Nifedipine and Atherogenesis
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The practical implementation of the results of large, well-controlled clinical and epidemiologic studies has led to substantial progress in the prevention of atherosclerosis. Now, daring and aggressive interventions, as well as a new understanding of cellular and molecular mechanisms of atherogenesis, also provide new possiblities of effective treatments at an advanced, symptomatic stage of the disease. An abundance of new information has come from an increasing number of seemingly unrelated scientific fields, ranging from laser optics to genetic engineering. This short study examines how some selected new findings and concepts fit into the traditional theories of atherogenesis: encrustation, infiltration, and response to injury. Endothelial and smooth muscle cells, platelets, and leukocytes are viewed in their dual capability of promoting as well as inhibiting the atherogenic process. Mechanisms of vascular healing and intimal hyperplasia after physical interventions are distinguished from those leading to complicated spontaneous atherosclerotic plaques, and the impact of some new ideas on potential pharmacologic interventions is brought to the reader's attention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Duguid JB. Pathogenesis of atherosclerosis.Lancet 1949;2:925–927.

    Article  PubMed  CAS  Google Scholar 

  2. Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarctions. A study of 107 necropsy patients.Am J Med 1972;52:425–433.

    Article  PubMed  CAS  Google Scholar 

  3. Anitschkow NN, Chalatow S. Ueber experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse.Z Allg Pathol 1913;24:1–19.

    Google Scholar 

  4. Goldstein JL, Brown MS, Anderson RG, et al. Receptormediated endocytosis: Concepts emerging from the LDL receptor system.Ann Rev Cell Biol 1985;1:1–39.

    Article  PubMed  CAS  Google Scholar 

  5. Babiak J, Rudel LL. Lipoproteins and atherosclerosis.Baillieres Clin Endocrinol Metab 1987;1:515–50.

    Article  PubMed  CAS  Google Scholar 

  6. Berg K. Predictive genetic testing of control coronary heart disease and hyperlipidemia.Arteriosclerosis 1989;9:150–158.

    Google Scholar 

  7. Stamler J, Shekelle R. Dietary cholesterol and human coronary heart disease. The epidemiologic evidence.Arch Pathol Lab Med 1988;112:1032–1040.

    PubMed  CAS  Google Scholar 

  8. Glagov S, Zarins C, Giddens DP, et al. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries.Arch Pathol Lab Med 1988;112:1018–1030.

    PubMed  CAS  Google Scholar 

  9. Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.Proc Natl Acad Sci USA 1989, in press.

  10. Haudenschild CC. Pathogenesis of restenosis.Kardiologie 1989;78:(suppl. 3):28–34.

    Google Scholar 

  11. Barger AC, Beeuwkes R 3rd, Lainey LL, et al. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis.N Engl J Med 1984;310:175–177.

    Article  PubMed  CAS  Google Scholar 

  12. Virchow R. Der atheromatose Prozess der Arterien.Wien Med Wochenschr 1856;6:825.

    Google Scholar 

  13. Stemermann MB, Ross R. Experimental arteriosclerosis: I. Fibrous plaque formation in primates: An electron microscope scope study.J Exp Med 1972;136:769–789.

    Article  PubMed  Google Scholar 

  14. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor.Cell 1986;46:155–169.

    Article  PubMed  CAS  Google Scholar 

  15. Grüntzig AR, Senning A, Siegenthaler WE. Non-operative dilation of coronary artery stenosis. Percutaneous transluminal coronary angioplasty.N Engl J Med 1979;301:61–68.

    Article  PubMed  Google Scholar 

  16. Faxon DP, Sanborn TA, Haudenschild CC, et al. Restenosis following transluminal angioplasty in experimental atherosclerosis.Arteriosclerosis 1984;4:189–195.

    PubMed  CAS  Google Scholar 

  17. Ross R. Atherosclerosis: A problem of the biology of arterial wall cells and their interactions with blood components.Arteriosclerosis 1981;1:293–311.

    PubMed  CAS  Google Scholar 

  18. Haudenschild CC, Studer A. Early interactions between blood cells and severely damaged rabbit aortae.Eur J Clin Invest 1971;2:1–7.

    Article  PubMed  CAS  Google Scholar 

  19. Born GV. Adenosine diphosphate as a mediator of platelet aggregation in vivo.Adv Exp Med Biol 1985;192:399–409.

    PubMed  CAS  Google Scholar 

  20. Cohen RA. Vascular responses to platelets. In: Nobin A, Owman C, Arneklo-Nobin B, eds.Neuronal messengers in vascular function. Amsterdam, New York: Elsevier, 1987:75–83.

    Google Scholar 

  21. Halushka PV, Mais DE, Saussy DL Jr. Platelets and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.Fed Proc 1987;46:149–153.

    PubMed  CAS  Google Scholar 

  22. Goldberg ID, Stemerman MB, Handin RI. Vascular permeation of platelet factor 4 after endothelial injury.Science 1980;209:611–613.

    Article  PubMed  CAS  Google Scholar 

  23. Ouchi Y, Hirosumi J, Watanabe M, et al. Inhibitory effect of transforming growth factor-beta on epidermal growth factor-induced proliferation of cultured rat aortic smooth muscle cells.Biochem Biophys Res Commun 1988;157:301–307.

    Article  PubMed  CAS  Google Scholar 

  24. Castellot JJ Jr, Favreau LV, Karnovsky MJ, et al. Inhibition of vascular smooth muscle cell growth by endothelial cell derived heparin: Possible role of platelet endoglycosidase.J Biol Chem 1982;257:11256–11260.

    PubMed  CAS  Google Scholar 

  25. Fuster V, Cohen M, Halperin J. Aspirin in the prevention of coronary disease.N Engl J Med 1989;321:183–185.

    Article  PubMed  CAS  Google Scholar 

  26. Schaffner T, Taylor K, Bartucci EJ, et al. Arterial foam cells exhibit distinctive immunomorphologic and histochemical features of macrophages.Am J Pathol 1980;100:57–80.

    PubMed  CAS  Google Scholar 

  27. Martin BM, Gimbrone MA Jr, Majeau GR, et al. Stimulation of human nonocyte/macrophage-derived growth factor (MDGF) production by plasma fibronectin.Am J Pathol 1983;111:357–373.

    Google Scholar 

  28. Joseph-Silverstein, Rifkin DB. Endothelial cell growth factors and the vessel wall.Seminars in Thrombosis and Hemostasis 1987;13:504–513.

    Article  PubMed  CAS  Google Scholar 

  29. Nathan CF. Secretory products of macrophages.J Clin Invest 1987;79:319–326.

    Article  PubMed  CAS  Google Scholar 

  30. Jonasson L, Holm J, Skalli O, et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.Arteriosclerosis 1986;6:131–138.

    PubMed  CAS  Google Scholar 

  31. Emerson EE, Robertson AL Jr. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.Am J Pathol 1988;120:369–376.

    Google Scholar 

  32. Seifert PS, Kazatchkine MD. The complement system in atherosclerosis.Atherosclerosis 1988;73:91–104.

    Article  PubMed  CAS  Google Scholar 

  33. Minick CR, Alonso DR, Rankin L. Role of immunologic arterial injury in atherogenesis.Thromb Haemost 1978;39:304–311.

    PubMed  CAS  Google Scholar 

  34. Benditt EP, Barett T, McDougal JK, Viruses in the etiology of atherosclerosis.Proc Natl Acad Sci USA 1983;80:6286–6389.

    Article  PubMed  Google Scholar 

  35. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: Atherogenesis and inflammation.Lab Invest 1988;58:249–261.

    PubMed  CAS  Google Scholar 

  36. DiCorleto PE. Chisholm GM 3rd. Participation of the endothelium in the development of the atherosclerotic plaque.Prog Lipid Res 1986;25:365–374.

    Article  PubMed  CAS  Google Scholar 

  37. Furchtgott RF. Role of endothelium in responses of vascular smooth muscle.Circulation 1983;53:557–573.

    Google Scholar 

  38. Castellot JJ Jr, Addonizio ML, Rosenberg R, et al. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.J Cell Biol 1981;90:372–379.

    Article  PubMed  CAS  Google Scholar 

  39. Haudenschild CC, Schwartz SM. Endothelial regeneration II. Restitution of endotheial continuity.Lab Invest 1979;41:407–418.

    PubMed  CAS  Google Scholar 

  40. Reidy MA, Silver M. Endothelial regeneration VII. Lack of intimal proliferation after defined injury to rat aorta.Am J Pathol 1985;118:173–177.

    PubMed  CAS  Google Scholar 

  41. Kawai Y, Montgomery RR. Endothelial processing of von Willebrand proteins.Ann NY Acad Sci 1987;509:60–70.

    Article  PubMed  CAS  Google Scholar 

  42. DiCorleto PE, Bowen-Pope DF. Cultured endothelial cells produce a platelet-derived growth factor-like protein.Proc Natl Acad Sci USA 1983;80:1919–1923.

    Article  PubMed  CAS  Google Scholar 

  43. Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule, ELAM 1.Proc Natl Acad Sci USA 1987;84:9238–9242.

    Article  PubMed  CAS  Google Scholar 

  44. Chester AH, Dashwood MR, Clarke JG, et al. Influence of endothelin on human coronary arteries and localization of its binding sites.Am J Cardiol 1989;63:1395–1398.

    Article  PubMed  CAS  Google Scholar 

  45. Hansson GK, Bondjers G. Endothelial dysfunction and injury in atherosclerosis.Acta Medica Scand Supplem 1987;715:11–17.

    CAS  Google Scholar 

  46. Campbell GR, Campbell JH, Manderson JA, et al. Arterial smooth muscle. A multifunctional mesenchymal cell.Arch Pathol Lab Med 1988;112:977–986.

    PubMed  CAS  Google Scholar 

  47. Yarden Y, Escobedo JA, Kuang WJ, et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.Nature 1986;323:226–232.

    Article  PubMed  CAS  Google Scholar 

  48. Hirosumi J, Ouchi Y, Watanabe M, et al. Effects of growth factors on cytosolic free calcium concentration and DNA synthesis in cultured rat aortic smooth muscle cells.Tohoku J Exp Med 1989;157:289–300.

    Article  PubMed  CAS  Google Scholar 

  49. Collen D, Juhan-Vague I. Fibronolysis and atherosclerosis.Semin Thromb Hemost 1988;14:180–183.

    Article  PubMed  CAS  Google Scholar 

  50. Goodnight SH, Fisher M, Fitzgerald GA, et al. Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis.Chest 1989;95:19S-25S.

    Article  PubMed  CAS  Google Scholar 

  51. Haudenschild CC. Restenosis: Basic considerations. In: Topol E. ed.Interventional cardiology, Philadelphia: Saunders, 1989, pp. 344–362.

    Google Scholar 

  52. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques.Proc Natl Acad Sci USA 1973;70:1753–1756.

    Article  PubMed  CAS  Google Scholar 

  53. Benditt EP. Origins of human atherosclerotic plaques. The role of altered gene expression.Arch Pathol Lab Med 1988;112:997–1001.

    PubMed  CAS  Google Scholar 

  54. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm.Circulation 1989;80:1–9.

    PubMed  CAS  Google Scholar 

  55. Henry PD. Calcium antagonists as antiatherogenic agents.Ann NY Acad Sci 1988;522:411–419.

    Article  PubMed  CAS  Google Scholar 

  56. Powell JS, Clozel JP, Muller RK, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.Science 1989;245:186–188.

    Article  PubMed  CAS  Google Scholar 

  57. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the watanabe heritable hyperlipidemic rabbit.Hypertension 1989;15(3):327–331.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mallory Institute of Pathology, Boston University School of Medicine, 784 Massachusetts Avenue, Boston, MA, USA

    Christian C. Haudenschild MD (Professor of Medicine, Mallory Institute of Pathology, Boston University School of Medicine)

Authors
  1. Christian C. Haudenschild MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haudenschild, C.C. Pathogenesis of atherosclerosis: State of the art. Cardiovasc Drug Ther 4 (Suppl 5), 993–1004 (1990). https://doi.org/10.1007/BF02018308

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018308

Key Words

Search

Navigation